Failure of acetabular components has been reported to lead to large bone defects, which determine outcome and management after revision total hip arthroplasty (THA). Although Kerboull-type (KT) plate (KYOCERA Medical Corporation, Kyoto, Japan) has been used for compensating large bone loss, few studies have identified the critical risk factors for failure of revision THA using a KT plate. Therefore, the aim of this study is to evaluate the relationship between survival rates for radiological loosening and the results according to bone defect or type of graft. This study included patients underwent revision THA for aseptic loosening using cemented acetabular components with a KT plate between 2000 and 2012. Bone defects were filled with beta Tricalcium phosphate (TCP) granules between 2000 and 2003 and with Hydroxyapatite (HA) block between 2003 and 2009. Since 2009, we have used femoral head balk allografts. Hip function was evaluated by using the Japanese Orthopaedic Association (JOA) score and University of California, Los Angeles (UCLA) activity. Acetabular defects were classified according to the American Academy of Orthopedic Surgeons (AAOS) classification. The postoperative and final follow-up radiographs were compared to assess migration of the implant. Kaplan–Meier method for cumulative probabilities of radiographic failure rate, and the comparison of survivorship curves for various subgroups using the log-rank test were also evaluated. Logistic regression was performed to examine the association of such clinical factors as the age at the time of operation, body mass index, JOA score, UCLA activity score, and AAOS classification with radiographic failure. Odds ratios (ORs) and 95% CIs were calculated. Multivariate analysis was performed to adjust for potential confounders by clinical factors. Values of Introduction
Patients and methods
Previously, the Coonrad-Morrey elbow system has typically been performed using linked-type total elbow arthroplasty (TEA) implants. However, this implant have been reported to be associated with some problems, such as wearing down, loosening, the complexity of the necessary surgical techniques and inappropriate implant size for Asian people. The Discovery elbow system (Biomet Inc., Warsaw, US) has recently been developed and it has many advantages when compared to Coonrad-Morrey implant, but the treatment outcome for this system is unclear in patients with rheumatoid arthritis (RA). The aim of this study was to clarify the outcome of TEA using the Discovery elbow system.Background
Objectives
We have compared the concentrations of stromal-cell-derived factor-1 (SDF-1), matrix metalloproteinase-1 (MMP-1), MMP-9 and MMP-13 in serum before and after synovectomy or total knee replacement (TKR). We confirmed the presence of SDF-1 and its receptor CXCR4 in the synovium and articular cartilage by immunohistochemistry. We established chondrocytes by using mutant CXCR4 to block the release of MMPs. The level of SDF-1 was decreased 5.1- and 6.7-fold in the serum of patients with OA and RA respectively, after synovectomy compared with that before surgery. MMP-9 and MMP-13 were decreased in patients with OA and RA after synovectomy. We detected SDF-1 in the synovium and the bone marrow but not in cartilage. CXCR4 was detected in articular cartilage. SDF-1 increased the release of MMP-9 and MMP-13 from chondrocytes in a dose-dependent manner. The mutant CXCR4 blocked the release of MMP-9 and MMP-13 from chondrocytes by retrovirus vector. Synovectomy is effective in patients with OA or RA because SDF-1, which can regulate the release of MMP-9 and MMP-13 from articular chondrocytes for breakdown of cartilage, is removed by the operation.
